Department of Pulmonology, Erasmus MC Rotterdam, Rotterdam, the Netherlands.
Cancer J. 2011 Jan-Feb;17(1):3-10. doi: 10.1097/PPO.0b013e3182099319.
Lung cancer with an estimated 342,000 deaths in 2008 (20% of total) is the most common cause of death from cancer, followed by colorectal cancer (12%), breast cancer (8%), and stomach cancer (7%) in Europe. In former smokers, the absolute lung cancer risk remains higher than in never-smokers; these data therefore call for effective secondary preventive measures for lung cancer in addition to smoking cessation programs. This review presents and discusses the most recent advances in the early detection and screening of lung cancer.An overview of randomized controlled computerized tomography-screening trials is given, and the role of bronchoscopy and new techniques is discussed. Finally, the approach of (noninvasive) biomarker testing in the blood, exhaled breath, sputum, and bronchoscopic specimen is reviewed.
2008 年,肺癌导致约 34.2 万人死亡(占癌症总死亡人数的 20%),是欧洲最常见的癌症死因,其次是结直肠癌(12%)、乳腺癌(8%)和胃癌(7%)。在曾经吸烟者中,肺癌的绝对风险仍然高于从不吸烟者;因此,除了戒烟计划外,这些数据还呼吁采取有效的肺癌二级预防措施。本综述介绍并讨论了肺癌早期检测和筛查的最新进展。概述了随机对照计算机断层扫描筛查试验,并讨论了支气管镜检查和新技术的作用。最后,还回顾了血液、呼气、痰液和支气管镜标本中(非侵入性)生物标志物检测的方法。